Global Health Epidemiology Reference Group (GHERG). Epidemiology of Alzheimer's disease and other forms of dementia in China, 1990-2010: a systematic review and analysis

Nossal Institute for Global Health, University of Melbourne, Australia.
The Lancet (Impact Factor: 45.22). 07/2013; 381(9882). DOI: 10.1016/S0140-6736(13)60221-4


Background China is increasingly facing the challenge of control of the growing burden of non-communicable diseases. We assessed the epidemiology of Alzheimer's disease and other forms of dementia in China between 1990, and 2010, to improve estimates of the burden of disease, analyse time trends, and inform health policy decisions relevant to China's rapidly ageing population. Methods In our systematic review we searched for reports of Alzheimer's disease or dementia in China, published in Chinese and English between 1990 and 2010. We searched China National Knowledge Infrastructure, Wanfang, and PubMed databases. Two investigators independently assessed case defi nitions of Alzheimer's disease and dementia: we excluded studies that did not use internationally accepted case defi nitions. We also excluded reviews and viewpoints, studies with no numerical estimates, and studies not done in mainland China. We used Poisson regression and UN demographic data to estimate the prevalence (in nine age groups), incidence, and standardised mortality ratio of dementia and its subtypes in China in 1990, 2000, and 2010. Findings Our search returned 12 642 reports, of which 89 met the inclusion criteria (75 assessed prevalence, 13 incidence, and nine mortality). In total, the included studies had 340 247 participants, in which 6357 cases of Alzheimer's disease were recorded. 254 367 people were assessed for other forms of dementia, of whom 3543 had vascular dementia, frontotemporal dementia, or Lewy body dementia. In 1990 the prevalence of all forms of dementia was 1·8% (95% CI 0·0–44·4) at 65–69 years, and 42·1% (0·0–88·9) at age 95–99 years. In 2010 prevalence was 2·6% (0·0–28·2) at age 65–69 years and 60·5% (39·7–81·3) at age 95–99 years. The number of people with dementia in China was 3·68 million (95% CI 2·22–5·14) in 1990, 5·62 million (4·42–6·82) in 2000, and 9·19 million (5·92–12·48) in 2010. In the same period, the number of people with Alzheimer's disease was 1·93 million (1·15–2·71) in 1990, 3·71 million (2·84–4·58) people in 2000, and 5·69 million (3·85–7·53) in 2010. The incidence of dementia was 9·87 cases per 1000 person-years, that of Alzheimer's disease was 6·25 cases per 1000 person-years, that of vascular dementia was 2·42 cases per 1000 person-years, and that of other rare forms of dementia was 0·46 cases per 1000 person-years. We retrieved mortality data for 1032 people with dementia and 20 157 healthy controls, who were followed up for 3–7 years. The median standardised mortality ratio was 1·94:1 (IQR 1·74–2·45). Interpretation Our analysis suggests that previous estimates of dementia burden, based on smaller datasets, might have underestimated the burden of dementia in China. The burden of dementia seems to be increasing faster than is generally assumed by the international health community. Rapid and eff ective government responses are needed to tackle dementia in low-income and middle-income countries.

Download full-text


Available from: Wei Wang,
  • Source
    • "Nevertheless, our study identified that decline in cognitive function is a risk factor for institutionalization. The role of cognitive decline as a risk factor for placement in elder care homes is of particular interest because China has more than nine million people with some form of dementia and more cases of Alzheimer's disease than any other country (Chan et al., 2013), and the growing population of cognitively impaired older adults (especially those with Alzheimer's and other forms of dementia) is presenting a huge challenge to Chinese health and social care systems (Khan & Loo, 2014; Upson, 2014). Unlike most developed countries, where the predominant objective of nursing homes is to provide care for persons who are physically or cognitively impaired, most elder care institutions in China tend to preferentially accept younger, healthier, or non-disabled older adults (Balfour, 2012; Dong & Wu, 2010; Span, 2011). "
    [Show abstract] [Hide abstract]
    ABSTRACT: To examine rates of institutionalization of Chinese older adults aged 65+ and the impact of changes in health status on the likelihood of institutionalization. Using data from the 2002, 2005, 2008, and 2011 waves of the Chinese Longitudinal Healthy Longevity Survey (CLHLS), admission rates for each 3-year interval between waves were calculated. Logistic regression models were used to assess the changes of five health status variables as risk factors. Between the first (2002-2005) and third (2008-2011) intervals, the institutionalization rate increased from 0.5% to 0.8%. Risk of institutionalization increased 70% for respondents with declining ability to perform activities of daily living, 53% for those with declining cognitive function, and 44% for those with increasing number of chronic diseases. Development of policies and programs to improve older adults' health status is essential to delay institutionalization. Quality of workforce is also critical in meeting the care needs. © The Author(s) 2015.
    Journal of Aging and Health 04/2015; 27(7). DOI:10.1177/0898264315577779 · 1.56 Impact Factor
  • Source
    • "Alzheimer's disease (AD) is rapidly becoming a major cause of morbidity and mortality as an increasing number of people live into their 70 and 80 s, the most common age of disease onset (Mayeux and Stern, 2012; Chan et al., 2013). AD is characterized by the progressive deterioration of cognitive function with an insidious impairment of short-term memory that becomes amplified to the point of inability to perform even the simplest tasks. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Humans have long pondered the nature of their mind/brain and, particularly why its capacities for reasoning, communication and abstract thought are far superior to other species, including closely related anthropoids. This article considers superior pattern processing (SPP) as the fundamental basis of most, if not all, unique features of the human brain including intelligence, language, imagination, invention, and the belief in imaginary entities such as ghosts and gods. SPP involves the electrochemical, neuronal network-based, encoding, integration, and transfer to other individuals of perceived or mentally-fabricated patterns. During human evolution, pattern processing capabilities became increasingly sophisticated as the result of expansion of the cerebral cortex, particularly the prefrontal cortex and regions involved in processing of images. Specific patterns, real or imagined, are reinforced by emotional experiences, indoctrination and even psychedelic drugs. Impaired or dysregulated SPP is fundamental to cognitive and psychiatric disorders. A broader understanding of SPP mechanisms, and their roles in normal and abnormal function of the human brain, may enable the development of interventions that reduce irrational decisions and destructive behaviors.
    Frontiers in Neuroscience 08/2014; 8(8):265. DOI:10.3389/fnins.2014.00265 · 3.66 Impact Factor
  • Source
    • "Alzheimer’s disease (AD) is the most common neurodegenerative disorder in the elderly people. The latest epidemiology study of AD reported that the number of people with the disease in China is significantly increased from 1.93 million in 1990 to 5.69 million in 2010 [1], representing a major health problem and a heavy financial burden on individuals and society as a whole. Clinically, AD is characterized by progressive and gradual decline in cognitive function, accompanying with severe memory loss and, ultimately, decreasing physical functions and death. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Alzheimer's disease (AD) is the most common neurodegenerative disorder affecting the elderly people. AD is characterized by progressive and gradual decline in cognitive function and memory loss. While familial early-onset AD is usually associated with gene mutations, the etiology of sporadic late-onset form of AD is largely unknown. It has been reported that environmental factors and epigenetic alterations significantly contribute to the process of AD. Our previous studies have documented that chronic hypoxia is one of the environmental factors that may trigger the AD development and aggravate the disease progression. In this review, we will summarize the pathological effects of chronic hypoxia on the onset and development of AD and put forward the possible molecule mechanisms underlying the chronic hypoxia mediated AD pathogenesis. Finally, we propose that epigenetic regulations may represent new opportunity for the therapeutic intervention of this disease.
    Translational Neurodegeneration 03/2014; 3(1):7. DOI:10.1186/2047-9158-3-7
Show more